Novo Holdings A/S - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2021$3,518,000
-46.5%
1,776,613
-7.9%
0.17%
-50.9%
Q3 2021$6,575,000
-65.8%
1,928,157
-18.3%
0.34%
-60.2%
Q2 2021$19,244,000
-33.7%
2,361,2290.0%0.85%
-28.8%
Q1 2021$29,043,000
-32.6%
2,361,2290.0%1.20%
-35.1%
Q4 2020$43,116,000
+315.3%
2,361,229
+255.1%
1.85%
+258.8%
Q3 2020$10,381,000665,0000.52%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 1,324,364$20,673,0007.35%
SECTORAL ASSET MANAGEMENT INC 842,851$13,157,0001.13%
TFG Asset Management GP Ltd 730,000$11,395,0001.05%
FRAZIER MANAGEMENT LLC 550,000$8,586,0000.77%
Eventide Asset Management 2,343,304$35,620,0000.70%
Novo Holdings A/S 665,000$10,381,0000.52%
Monashee Investment Management LLC 94,911$1,482,0000.32%
Ovata Capital Management Ltd 37,500$585,0000.21%
Woodline Partners LP 206,413$3,222,0000.11%
Hound Partners 70,000$1,093,0000.07%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders